Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
Terns Pharmaceuticals, Inc. Common Stock (TERN) News
Latest headlines that mention TERN, newest first · each headline opens the original publisher
- Last price
- $52.95
- Day change
- +0.04%
- Next earnings
- —
TERN headlines
latest coverageNot much coverage yet. TERN has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Merck & Co. is seeking to raise about $6 billion from an investment-grade bond sale to help finance its acquisition of Terns Pharmaceuticals Inc., according to people familiar with the matter.
TERN news alerts
Get an alert by email or push when a new headline mentions TERN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.